Børretzen, A., Gravdal, K., Haukaas, S. A., Beisland, C., Akslen, L. A., & Halvorsen, O. J. (2019). FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. J Pathol Clin Res.
Citación estilo ChicagoBørretzen, Astrid, Karsten Gravdal, Svein A. Haukaas, Christian Beisland, Lars A. Akslen, y Ole J. Halvorsen. "FOXC2 Expression and Epithelial–mesenchymal Phenotypes Are Associated With Castration Resistance, Metastasis and Survival in Prostate Cancer." J Pathol Clin Res 2019.
Cita MLABørretzen, Astrid, et al. "FOXC2 Expression and Epithelial–mesenchymal Phenotypes Are Associated With Castration Resistance, Metastasis and Survival in Prostate Cancer." J Pathol Clin Res 2019.